Global Advisory Committee on Vaccine Safety

International committee advising on vaccine safety

Logo of the World Health Organization

The Global Advisory Committee on Vaccine Safety (GACVS) is an expert group established by the World Health Organization (WHO) to provide independent, scientifically rigorous advice on issues related to the safety of vaccines. The committee plays a crucial role in ensuring that vaccines are safe and effective, thereby maintaining public confidence in immunization programs worldwide.

History

The GACVS was established in 1999 in response to growing concerns about vaccine safety and the need for a global body to address these issues. Since its inception, the committee has been instrumental in evaluating vaccine safety data and providing guidance to the WHO and its member states.

Mandate and Functions

The primary mandate of the GACVS is to provide independent scientific advice on vaccine safety issues of global importance. The committee reviews and assesses vaccine safety data, identifies potential safety concerns, and recommends actions to mitigate risks. It also advises on the development of new vaccines and the monitoring of vaccine safety post-licensure.

Composition

The GACVS is composed of experts from various fields, including epidemiology, immunology, pharmacology, and public health. Members are selected based on their expertise and experience in vaccine safety and related areas. The committee meets biannually, and its recommendations are published in the WHO Weekly Epidemiological Record.

Key Activities

The GACVS conducts regular reviews of vaccine safety data, focusing on vaccines that are of global importance. It evaluates reports of adverse events following immunization (AEFI) and provides guidance on risk assessment and communication. The committee also collaborates with national and regional vaccine safety advisory bodies to harmonize safety monitoring efforts.

Impact

The work of the GACVS has been pivotal in maintaining public trust in vaccines. By providing transparent and evidence-based recommendations, the committee helps to address public concerns and misinformation about vaccine safety. Its guidance has been crucial in the introduction of new vaccines and the management of vaccine safety crises.

Challenges

The GACVS faces several challenges, including the need to rapidly assess emerging safety concerns and the increasing complexity of vaccine technologies. The committee must also address the challenges posed by misinformation and vaccine hesitancy, which can undermine public confidence in vaccination programs.

Related pages

• World Health Organization
• Vaccine
• Vaccine safety
• Adverse event following immunization